An Industry Perspective: Future of Anti-Amyloid Trials

被引：0
|
作者：
Lynn D. Kramer
机构：
[1] Eisai Inc.,
来源：
The Journal of Prevention of Alzheimer's Disease | 2020年 / 7卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：142 / 143
页数：1
相关论文
共 50 条
  • [1] An Industry Perspective: Future of Anti-Amyloid Trials
    Kramer, Lynn D.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2020, 7 (03): : 142 - 143
  • [2] The Future of Anti-Amyloid Trials
    Aisen, P. S.
    Cummings, J.
    Doody, R.
    Kramer, L.
    Salloway, S.
    Selkoe, D. J.
    Sims, J.
    Sperling, R. A.
    Vellas, B.
    Abushakra, Susan
    Aisen, Paul
    Alam, John
    Andrieu, Sandrine
    Bansal, Anu
    Baudler, Monika
    Bell, Joanne
    Beraud, Mickael
    Bittner, Tobias
    Haeberlein, Samantha Budd
    Bullain, Szofia
    Cantillon, Marc
    Carrillo, Maria
    Castrillo-Viguera, Carmen
    Cheung, Ivan
    Coelho, Julia
    Cummings, Jeffrey
    Detke, Michael
    Di Giusto, Daniel
    Doody, Rachelle
    Dwyer, John
    Egan, Michael
    Ewen, Colin
    Fisher, Charles
    Gauthier, Serge
    Gold, Michael
    Hampel, Harald
    He, Ping
    Hendrix, Suzanne
    Henley, David
    Irizarry, Michael
    Iwata, Atsushi
    Iwatsubo, Takeshi
    Keeley, Michael
    Kerchner, Geoffrey
    Kinney, Gene
    Kolb, Hartmuth
    Kosco-Vilbois, Marie
    Kramer, Lynn
    Kurzman, Ricky
    Lannfelt, Lars
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2020, 7 (03): : 146 - 151
  • [3] The Future of Anti-Amyloid Trials
    P. S. Aisen
    J. Cummings
    R. Doody
    L. Kramer
    S. Salloway
    D. J. Selkoe
    J. Sims
    R. A. Sperling
    B. Vellas
    The Journal of Prevention of Alzheimer's Disease, 2020, 7 : 146 - 151
  • [4] The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report
    Julien Delrieu
    R. J. Bateman
    J. Touchon
    M. Sabbagh
    J. Cummings
    The Journal of Prevention of Alzheimer's Disease, 2022, 9 : 393 - 399
  • [5] The EU/US Task Force’s Future for Anti-Amyloid Trials: Faites Vos Jeux
    Lon S. Schneider
    The Journal of Prevention of Alzheimer's Disease, 2020, 7 : 199 - 200
  • [6] The EU/US Task Force's Future for Anti-Amyloid Trials: Faites Vos Jeux
    Schneider, Lon S.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2020, 7 (03): : 199 - 200
  • [7] The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report
    Delrieu, J.
    Bateman, R. J.
    Touchon, J.
    Sabbagh, M.
    Cummings, J.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2022, 9 (03): : 393 - 399
  • [8] Anti-Amyloid Monoclonal Antibodies: Mechanisms of Action and Clinical Trials
    Rafii, Michael
    ANNALS OF NEUROLOGY, 2023, 94 : S281 - S281
  • [9] AMYLOID AND COGNITIVE FUNCTION Anti-amyloid trials raise scientific and ethical questions
    Smith, A. David
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [10] Rate of β-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials
    Guo, Tengfei
    Dukart, Juergen
    Brendel, Matthias
    Rominger, Axel
    Grimmer, Timo
    Yakushev, Igor
    ALZHEIMERS & DEMENTIA, 2018, 14 (11) : 1387 - 1396
12345